Long-term remission and biologic persistence rates: 12-year real-world data

BACKGROUND: Biologic therapies have greatly improved outcomes in rheumatoid arthritis (RA) and psoriatic arthritis (PsA). Yet, our ability to predict long-term remission and persistence or continuation of therapy remains limited. This study explores predictors of remission and persistence of the ini...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, Kieran, Turk, Matthew, Alammari, Yousef, Young, Francis, Gallagher, Phil, Saber, Tajvur, Fearon, Ursula, Veale, Douglas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807520/
https://www.ncbi.nlm.nih.gov/pubmed/33441191
http://dx.doi.org/10.1186/s13075-020-02380-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807520/
https://www.ncbi.nlm.nih.gov/pubmed/33441191
http://dx.doi.org/10.1186/s13075-020-02380-z

Ejemplares similares